These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 25298141

  • 1. Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine.
    Ito T, Mochizuki K, Oka T, Hanada K, Tanabe K.
    Int Urol Nephrol; 2015 Jan; 47(1):131-5. PubMed ID: 25298141
    [Abstract] [Full Text] [Related]

  • 2. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
    Saito T, Iwano M, Matsumoto K, Mitarai T, Yokoyama H, Yorioka N, Nishi S, Yoshimura A, Sato H, Ogahara S, Sasatomi Y, Kataoka Y, Ueda S, Koyama A, Maruyama S, Nangaku M, Imai E, Matsuo S, Tomino Y, Refractory Nephrotic Syndrome Study Group.
    Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
    [Abstract] [Full Text] [Related]

  • 3. Mizoribine for the treatment of lupus nephritis in children and adolescents.
    Tanaka H, Tsugawa K, Tsuruga K, Suzuki K, Nakahata T, Ito E, Waga S.
    Clin Nephrol; 2004 Dec; 62(6):412-7. PubMed ID: 15630899
    [Abstract] [Full Text] [Related]

  • 4. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W, Suganuma S, Uchida K, Moriyama T, Otsubo S, Takei T, Naito M, Koike M, Nitta K, Nihei H.
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
    Matsumoto Y, Shimada Y, Nojima Y, Moriki T.
    Ren Fail; 2013 Aug; 35(7):936-41. PubMed ID: 23815417
    [Abstract] [Full Text] [Related]

  • 6. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis with anti-glomerular basement membrane antibodies that was successfully treated with mizoribine as a safe and effective remission maintenance therapy with prednisolone and plasma exchange.
    Ikeda Y, Fukunari K, Uchiumi S, Awanami Y, Kanaya A, Matsumoto K, Fukuda M, Takashima T, Miyazono M, Ikeda Y.
    CEN Case Rep; 2020 Feb; 9(1):42-47. PubMed ID: 31612361
    [Abstract] [Full Text] [Related]

  • 7. Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
    Nishioka Y, Horita Y, Tadokoro M, Taura K, Suyama N, Miyazaki M, Harada T, Kohno S.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2337-8. PubMed ID: 16547120
    [No Abstract] [Full Text] [Related]

  • 8. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 9. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
    Goto M, Ikeda M, Hataya H, Ishikura K, Hamasaki Y, Honda M.
    Nihon Jinzo Gakkai Shi; 2006 Jun; 48(4):365-70. PubMed ID: 16780106
    [Abstract] [Full Text] [Related]

  • 10. Long-term open-trial of mizoribine with prednisolone in 24 patients with multiple sclerosis: safety, clinical and magnetic resonance imaging outcome.
    Saida K, Zhigang Z, Ozawa K, Konishi T, Saida T.
    Intern Med; 1999 Aug; 38(8):636-42. PubMed ID: 10440499
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of mizoribine by one single dose administration for patients with rheumatoid arthritis.
    Ichinose K, Origuchi T, Kawashiri SY, Iwamoto N, Fujikawa K, Aramaki T, Kamachi M, Arima K, Tamai M, Nakamura H, Ida H, Kawakami A, Tsukada T, Ueki Y, Eguchi K.
    Intern Med; 2010 Aug; 49(20):2211-8. PubMed ID: 20962439
    [Abstract] [Full Text] [Related]

  • 12. The efficacy and safety of high-dose mizoribine in ABO-incompatible kidney transplantation using anti-CD20 and anti-CD25 antibody without splenectomy treatment.
    Yoshimura N, Ushigome H, Matsuyama M, Nobori S, Suzuki T, Sakai K, Okajima H, Okamoto M.
    Transplant Proc; 2012 Jan; 44(1):140-3. PubMed ID: 22310599
    [Abstract] [Full Text] [Related]

  • 13. Effect of mizoribine pulse therapy in adult membranous nephropathy.
    Wang X, Zhang M, Zhang W, Liu Y, Han Y, Chang W.
    Int Urol Nephrol; 2021 Apr; 53(4):725-731. PubMed ID: 33159256
    [Abstract] [Full Text] [Related]

  • 14. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
    Zhang M, Xing CY, Liu J.
    Rheumatol Int; 2013 Nov; 33(11):2737-42. PubMed ID: 23797779
    [Abstract] [Full Text] [Related]

  • 15. Assessment of factors associated with mizoribine responsiveness in children with steroid-dependent nephrotic syndrome.
    Kondoh T, Ikezumi Y, Yokoi K, Nakajima Y, Matsumoto Y, Kaneko M, Hasegawa H, Yamada T, Kumagai N, Ito T, Yoshikawa T.
    Clin Exp Nephrol; 2019 Sep; 23(9):1154-1160. PubMed ID: 31187341
    [Abstract] [Full Text] [Related]

  • 16. Mizoribine combined with steroids and dietary sodium restriction on the treatment of primary membranous nephropathy: a prospective study.
    Wang X, Zhang M, Sun N, Chang W.
    Clin Exp Nephrol; 2023 Mar; 27(3):211-217. PubMed ID: 36574107
    [Abstract] [Full Text] [Related]

  • 17. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 18. A case of lupus nephritis improved after appropriately adjusting the dosage of mizoribine.
    Tsubouchi Y, Fukuda W, Kawahito Y, Kohno M, Wada M, Ishino H, Hamaguchi M, Yamamoto A, Kadoya M, Niimi M, Yoshikawa T.
    Mod Rheumatol; 2008 Jul; 18(1):91-5. PubMed ID: 18159569
    [Abstract] [Full Text] [Related]

  • 19. Usefulness and safety of high-dose mizoribine on ABO-incompatible living related kidney transplantation using anti-CD20 and anti-CD25 antibodies without splenectomy: 3-year results.
    Yoshimura N, Ushigome H, Nobori S, Suzuki T, Sakai K, Koshino K, Nakamura T, Nakao T, Harada S, Ito T.
    Transplant Proc; 2014 Jul; 46(2):391-4. PubMed ID: 24655971
    [Abstract] [Full Text] [Related]

  • 20. Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome.
    Tanaka H, Tsugawa K, Nakahata T, Kudo M, Onuma S, Kimura S, Ito E.
    Tohoku J Exp Med; 2005 Jan; 205(1):87-91. PubMed ID: 15635277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.